bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
Khresmoi - new !
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2019: S A J J M A M F J
2018: D N O S

 
  Other news for:
Substance-Related Disorders
Street Drugs
 Resources from HONselect
Fentanyl Becoming a Deadly Accomplice in Cocaine, Meth Abuse

By Robert Preidt

MONDAY, May 6, 2019 (HealthDay News) -- As if using cocaine or methamphetamines isn't risky enough, new research shows a sharp spike in urine drug tests that are positive for those drugs and the powerful synthetic opioid fentanyl.

The findings could provide insight into steeply rising rates of cocaine- and methamphetamine-related overdoses in the United States.

For the study, researchers analyzed data on one million urine drug tests taken in various medical settings. The investigators found that between January 2013 and September 2018, the presence of fentanyl in urine drug tests that were also positive for cocaine or methamphetamine rose 1,850% and 798%, respectively.

Those statistics suggest that increases in cocaine- and methamphetamine-related overdoses may be related to fentanyl either being added to those drugs or used at the same time, according to the authors of the study published online recently in JAMA Network Open.

Research published just last week came to similar conclusions, but from a different angle: Nearly three-quarters of cocaine-involved deaths in 2017 also involved opioids, as did about half of deaths involving psychostimulants such as meth. Synthetic opioids -- fentanyl, most prominently -- often played a key and deadly role, researchers from the U.S. Centers for Disease Control and Prevention found.

In the latest study, the urine tests were ordered by health care providers in numerous areas of medicine, including pain management, primary care, addiction treatment, behavioral health, obstetrics and gynecology, and multi-specialties.

Positive results for cocaine or methamphetamine with non-prescribed fentanyl were seen across all of them, suggesting abuse is happening in many care settings, the researchers noted.

"The increasingly common concurrent use of fentanyl with cocaine or methamphetamine may help explain the recent sharp increases in overdose deaths involving stimulants," said study co-author Bob Twillman. He is a consultant with the drug testing company Millennium Health, based in San Diego.

"It is still undetermined if these combinations are created by dealers or users, and if by users, if this simply reflects a shift from heroin to fentanyl as the opioid being used," he added in a company news release.

"Clinicians and patients both should be aware of the potential consequences of fentanyl exposure, knowingly or unknowingly, and take the necessary steps to maximize patient safety," Twillman concluded.

More information

The U.S. Centers for Disease Control and Prevention has more on fentanyl.

SOURCE: Millennium Health, news release, May 1, 2019

Copyright © 2019 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=745855

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Fentanyl
Urine
Research Personnel
Methamphetamine
Specialty Chemicals and Products
Overdose
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Home img About us img MediaCorner img HON newsletter img Site map img Ethical policies img Contact